EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF
A 4-substituted-2-(N-(5-substituted allyl amide)phenyl)amino)pyrimidine derivative as represented by formula (I), and a preparation and application thereof as an EGFR inhibitor. The compound has activity of inhibiting the L858R EGFR mutant, the T790M EGFR mutant and the exon 19 deletion activating m...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WANG, Shaobao SUN, Guangjun TAN, Songliang WEI, Mingsong BAO, Rudi XIU, Wenhua ZHANG, Fujun GAO, Peng |
| description | A 4-substituted-2-(N-(5-substituted allyl amide)phenyl)amino)pyrimidine derivative as represented by formula (I), and a preparation and application thereof as an EGFR inhibitor. The compound has activity of inhibiting the L858R EGFR mutant, the T790M EGFR mutant and the exon 19 deletion activating mutant, may be used to treat diseases mediated alone or in part by EGFR mutant activity, and has a wide application in drugs preventing and treating cancers, particularly non-small cell lung cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3205650B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3205650B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3205650B13</originalsourceid><addsrcrecordid>eNrjZDB3dXcLUvD08_B08gzxD9JRcPRzUQgIcg1wDHIM8fT3A_MdAwJ8PJ0h_BAP1yBXfzceBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBsZGBqZmrgZGhMhBIA1lgnlg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF</title><source>esp@cenet</source><creator>WANG, Shaobao ; SUN, Guangjun ; TAN, Songliang ; WEI, Mingsong ; BAO, Rudi ; XIU, Wenhua ; ZHANG, Fujun ; GAO, Peng</creator><creatorcontrib>WANG, Shaobao ; SUN, Guangjun ; TAN, Songliang ; WEI, Mingsong ; BAO, Rudi ; XIU, Wenhua ; ZHANG, Fujun ; GAO, Peng</creatorcontrib><description>A 4-substituted-2-(N-(5-substituted allyl amide)phenyl)amino)pyrimidine derivative as represented by formula (I), and a preparation and application thereof as an EGFR inhibitor. The compound has activity of inhibiting the L858R EGFR mutant, the T790M EGFR mutant and the exon 19 deletion activating mutant, may be used to treat diseases mediated alone or in part by EGFR mutant activity, and has a wide application in drugs preventing and treating cancers, particularly non-small cell lung cancer.</description><language>eng ; fre ; ger</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210804&DB=EPODOC&CC=EP&NR=3205650B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210804&DB=EPODOC&CC=EP&NR=3205650B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WANG, Shaobao</creatorcontrib><creatorcontrib>SUN, Guangjun</creatorcontrib><creatorcontrib>TAN, Songliang</creatorcontrib><creatorcontrib>WEI, Mingsong</creatorcontrib><creatorcontrib>BAO, Rudi</creatorcontrib><creatorcontrib>XIU, Wenhua</creatorcontrib><creatorcontrib>ZHANG, Fujun</creatorcontrib><creatorcontrib>GAO, Peng</creatorcontrib><title>EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF</title><description>A 4-substituted-2-(N-(5-substituted allyl amide)phenyl)amino)pyrimidine derivative as represented by formula (I), and a preparation and application thereof as an EGFR inhibitor. The compound has activity of inhibiting the L858R EGFR mutant, the T790M EGFR mutant and the exon 19 deletion activating mutant, may be used to treat diseases mediated alone or in part by EGFR mutant activity, and has a wide application in drugs preventing and treating cancers, particularly non-small cell lung cancer.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB3dXcLUvD08_B08gzxD9JRcPRzUQgIcg1wDHIM8fT3A_MdAwJ8PJ0h_BAP1yBXfzceBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBsZGBqZmrgZGhMhBIA1lgnlg</recordid><startdate>20210804</startdate><enddate>20210804</enddate><creator>WANG, Shaobao</creator><creator>SUN, Guangjun</creator><creator>TAN, Songliang</creator><creator>WEI, Mingsong</creator><creator>BAO, Rudi</creator><creator>XIU, Wenhua</creator><creator>ZHANG, Fujun</creator><creator>GAO, Peng</creator><scope>EVB</scope></search><sort><creationdate>20210804</creationdate><title>EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF</title><author>WANG, Shaobao ; SUN, Guangjun ; TAN, Songliang ; WEI, Mingsong ; BAO, Rudi ; XIU, Wenhua ; ZHANG, Fujun ; GAO, Peng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3205650B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2021</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>WANG, Shaobao</creatorcontrib><creatorcontrib>SUN, Guangjun</creatorcontrib><creatorcontrib>TAN, Songliang</creatorcontrib><creatorcontrib>WEI, Mingsong</creatorcontrib><creatorcontrib>BAO, Rudi</creatorcontrib><creatorcontrib>XIU, Wenhua</creatorcontrib><creatorcontrib>ZHANG, Fujun</creatorcontrib><creatorcontrib>GAO, Peng</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WANG, Shaobao</au><au>SUN, Guangjun</au><au>TAN, Songliang</au><au>WEI, Mingsong</au><au>BAO, Rudi</au><au>XIU, Wenhua</au><au>ZHANG, Fujun</au><au>GAO, Peng</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF</title><date>2021-08-04</date><risdate>2021</risdate><abstract>A 4-substituted-2-(N-(5-substituted allyl amide)phenyl)amino)pyrimidine derivative as represented by formula (I), and a preparation and application thereof as an EGFR inhibitor. The compound has activity of inhibiting the L858R EGFR mutant, the T790M EGFR mutant and the exon 19 deletion activating mutant, may be used to treat diseases mediated alone or in part by EGFR mutant activity, and has a wide application in drugs preventing and treating cancers, particularly non-small cell lung cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3205650B1 |
| source | esp@cenet |
| subjects | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T04%3A48%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WANG,%20Shaobao&rft.date=2021-08-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3205650B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |